ARTICLE | Clinical News
RT001: Phase IIb data
November 1, 2010 7:00 AM UTC
A double-blind, U.S. Phase IIb trial in 90 patients showed that RT001 met the composite primary endpoint of a >=2-point improvement on both sides of the face as graded by the investigator's assessment...